Keyword: Racing Medication and Testing Consortium

  • Ky. Talks Timing of Steroid Rules

    The Racing Medication and Testing Consortium has funded a research project to study threshold levels and withdrawal times of four approved anabolic steroids. But the timing of the study, which should be completed by August, could make it difficult for the Kentucky Horse Racing Authority to implement steroid regulations in the state by Jan. 1, 2009.

  • Commission May Appeal Drug Ruling

    After the Louisiana Senate Commerce Committee struck down the Louisiana State Racing Commission's adoption of the Racing Medication and Testing Consortium model rules for medication Feb. 11, the commission is yet to decide its next move.

  • NTRA president and chief executive officer Alex Waldrop

    Waldrop to Testify on Capitol Hill

    National Thoroughbred Racing Association president and chief executive officer Alex Waldrop has been asked to testify in Washington, D.C., during a hearing titled "Drugs in Sports: Compromising the Health of Athletes and Undermining the Integrity of Competition."

  • Regulator: Stop Steroid Use Now

    A national regulator said uniform implementation of regulations for anabolic steroids in racehorses isn't practical and suggested horsemen "come clean to the races" voluntarily beginning April 1.

  • RMTC: Regulate Steroids Uniformly

    Members of the Racing Medication and Testing Consortium haven't backed away from a call for regulation of anabolic steroids in racehorses, but on Jan. 31 they endorsed a Dec. 31, 2008, deadline for nationwide adoption of a model rule.

  • Cohesive Rules for Steroids Sought

    The head of a major horsemen's group in the United States has proposed a national approach for regulation of anabolic steroids in racehorses with an implementation date of Jan. 1, 2009.

  • Kentucky Moves to Regulate Steroids

    The Kentucky Horse Racing Authority supports the regulation of anabolic steroids in racehorses in the state, and took the first step toward drafting and adopting the revised model rule offered by the Association of Racing Commissioners International and Racing Medication and Testing Consortium during a Dec. 17 meeting.

  • The Delaware Park paddock

    Delaware Panel Issues Steroids Ban

    Efforts by regulators in the Mid-Atlantic region to ban the use of steroids in racehorses continued Dec. 14 with an announcement by the Delaware Thoroughbred Racing Commission that the substances would be outlawed when Delaware Park opens for live racing in 2008.

  • The six mid-Atlantic state (in green) will ban the use of steroids in racehorses effective April 1, 2008.

    Mid-Atlantic Steroids Ban Official

    As expected, states in the Mid-Atlantic region have announced they are working to implement a ban on anabolic steroids in racehorses effective April 1, 2008.

  • Drug Consortium Announces Two Hires

    The Racing Medication and Testing Consortium has hired Dr. William Muir as research coordinator and Hallie Roach as communications coordinator.

  • Auction

    Steroid Policy Implemented at Sales

    Keeneland Association and Fasig-Tipton Co. officials jointly announced Nov. 15 that the policy regarding exogenous anabolic steroids will be implemented for weanlings and yearlings beginning with their 2008 sales.

  • Racing Medication Panel Refocused on Core Issues

    After nearly five years in existence, the Racing Medication and Testing Consortium is refocusing on some of its core goals such as uniform rules, drug research, and standardizing drug-testing procedures in the United States.

  • RMTC Refocusing on Drug Testing, Uniformity

    After nearly five years in existence, the Racing Medication and Testing Consortium is refocusing on some of its core goals such as uniform rules, drug research, and standardizing drug-testing procedures in the United States.

  • Commentary: Adjusting the Focus

    <i>By Dr. Scott Stanley and Dr. Rick Arthur</i> - Horse racing was ahead of other sports in implementing a drug-testing program, and in many ways we are still the pace­setters. We cast a broader net for more drugs than any other sport.

  • Medication Consortium Gets $300,000 in Contributions

    The Racing Medication and Testing Consortium received $100,000 contributions from the New York Racing Association and the United States Trotting Association, and $50,000 contributions from the Delaware Thoroughbred Horsemen's Association and the Hambletonian Society, the organization announced July 26.

  • Ray Paulick&lt;br&gt;Editor-in-Chief

    Commentary: Forked Tongue

    <i>By Ray Paulick</i> - Included in that "it's not illegal if you can't test for it" category is cobra venom, the use of which has been rumored for years. The substance, believed to be 1,000 times more powerful than morphine, can help a horse run through pain by blocking impulses through the nervous system. Use of the substance in horse racing is illegal. Worse yet, it's cruel to the animal.

  • Regulators Consider Anabolic Steroid Limits

    A model rule that limits anabolic steroid use to four approved substances was unanimously passed in a committee hearing of the Racing Commissioners International annual conference April 23, highlighting the opening-day morning session of the annual conference of North American regulators in Jackson Hole, Wyo.

  • RMTC Approves Sending Model Rules to RCI

    The board of directors of the Racing Medication and Testing Consortium (RMTC) passed a model rule on anabolic steroids that will be forwarded to the Association of Racing Commissioners International (RCI) for approval during the RCI Annual Convention April 23-27. After the RMTC receives input from the RCI, the model rule language will be released to the industry.

  • Drug Contaminants, 'Zero Tolerance' on Collision Course

    Research shows small amounts of stimulants and therapeutic drugs can be detected in stalls and other locations on the backstretch, and that has horsemen concerned given sensitive testing methods and regulations that don't make provisions for environmental contamination.

  • Dr. Rick Arthur, equine medical director for the California Horse Racing Board.

    CHRB Committee Urges Drug Policy Changes

    The California Horse Racing Board, under fire for its drug enforcement policies, would dramatically change penalties for many violations and repeat offenses under recommendations passed on to the full commission by its medication committee Jan. 9.

  • CHRB&#39;s Dr. Rick Arthur; &quot;...all licensees will be subject to the penalty guidelines.&quot;

    CHRB Committee to Tackle Medication Regulations

    The California Horse Racing Board Medication Committee will consider major changes to the state's medication rules and penalties during a meeting Jan. 9 at Santa Anita Park.

  • Regulation, Reclassification of Steroids Looming

    Racing officials Dec. 7 confirmed a push for regulation of anabolic steroids, and also said the therapeutic substances could be upgraded to Class 3 under Association of Racing Commissioners International guidelines by April 2007.

  • Dr. Rick Arthur, equine medical director for the California Horse Racing Board.

    Regulation of Steroids to be Recommended

    Members of the Racing Medication and Testing Consortium are expected to recommend regulation of anabolic steroids in racehorses, but the timetable for the regulations remains up in the air.

  • RMTC Addresses Future Plans; Retains Gallagher as Consultant

    During its meeting Nov. 2, in Louisville, Ky., the board of directors of the Racing Medication and Testing Consortium (RMTC) announced future plans regarding anabolic steroids and out-of-competition drug testing, and received an update on ongoing projects related to the development of withdrawal times for therapeutic medications.

  • Kentucky Equine Drug Research Council Commits $1.5 Million to RMTC Project

    In a meeting Oct. 9, the Kentucky Equine Drug Research Council committed $1.5 million to fund a three-year program with the Racing Medication and Testing Consortium that will research and determine appropriate withdrawal guidelines for therapeutic medications commonly administered to racehorses in training.

  • Drug Consortium Gets Boost From Hambo Society

    Members of the Hambletonian Society said they've made personal and collective commitments to raise $100,000 for the continued funding of the Racing Medication and Testing Consortium. The decision was made at the July meeting of the society, which has been involved with the RMTC since last year.

  • RMTC Works on Steroids Policy, Withdrawal Times

    The Racing Medication and Testing Consortium plans to recommend a model policy on anabolic steroids later this year and also has approved a plan to establish model policies for withdrawal times for therapeutic drugs used in racehorses.

  • Medication Consortium Ramps Up Projects, Fund-Raising Plan

    The national Racing Medication and Testing Consortium, which has succeeded in getting most or all of its model rules package for raceday medication and drug testing approved in a majority of jurisdictions, is officially seeking financial commitments from industry stakeholders to support ongoing integrity efforts.

  • Horsemen: No Tolerance for 'Zero Tolerance'

    Representatives of affiliates of the National Horsemen's Benevolent and Protective Association indicated Jan. 22 they support uniformity in medication and drug testing but need clear guidelines and consistent interpretation of the rules by sometimes overzealous regulators and stewards.

  • National HBPA to Address Drug Trace Levels

    The National Horsemen's Benevolent and Protective Association medication committee hopes to establish what it calls "proper regulatory thresholds" for trace levels of the urinary metabolites of cocaine and morphine.

  • Call Goes Out to Fund Medication Consortium

    The Racing Medication and Testing Consortium expects to have enough money to carry it through 2006, but an official with the group indicated it's imperative more racetrack and horsemen's associations commit funds to the organization.

  • RMTC Addresses Withdrawal Guidelines

    The Board of Directors of the Racing Medication and Testing Consortium (RMTC) commissioned Dr. Rick Sams of Ohio State to develop an action plan, timeline, and research priorities to establish guidelines for withdrawal times for therapeutic medications commonly used by racetrack veterinarians.